title: Extensive intracranial arterial stenoses in conjunction with the use of tyrosine kinase inhibitor Nilotinib.
abstract: New-generation tyrosine kinase inhibitors (TKI) are promising agents for the treatment of chronic myeloid leukemia (CML), but the linkage to vascular diseases warrants a special attention from treating physicians, as it may carry major morbidity and mortality.
authors.affiliation: Department of Neurology SUNY Upstate Medical University Syracuse New York USA.
authors.forename: Ruham
authors.identifier: 0000-0001-6600-3181
authors.initials: R
authors.lastname: Alshiekh-Nasany
authors.affiliation: Department of Neurology SUNY Upstate Medical University Syracuse New York USA.
authors.forename: Awss
authors.initials: A
authors.lastname: Zidan
authors.affiliation: Department of Neurology SUNY Upstate Medical University Syracuse New York USA.
authors.forename: Carmen
authors.initials: C
authors.lastname: Martinez
keywords: Cerebrovascular disease; Moyamoya; Nilotinib; stroke; tyrosine kinase